Skip to main content

Table 3 Late treatment-related complications

From: Minimally invasive surgery alone compared with intensity-modulated radiotherapy for primary stage I nasopharyngeal carcinoma

Complications

ENPG (N = 10)

IMRT (N = 220)

P*

n

%

n

%

Auditory/hearing

0.069

 0

10

100

138

62.7

 

 1–2

0

0

63

28.7

 

 3–4

0

0

19

8.6

 

Trismus

0.369

 0

10

100

184

83.6

 

 1–2

0

0

36

16.4

 

 3–4

0

0

0

0

 

Dysphagia

0.674

 0

10

100

190

86.4

 

 1–2

0

0

26

11.8

 

 3–4

0

0

4

1.8

 

Skin

    

1.000

 0

9

90.0

193

87.7

 

 1–2

1

10.0

25

11.4

 

 3–4

0

0

2

0.9

 

Subcutaneous soft tissue

0.611

 0

10

100

193

87.7

 

 1–2

0

0

27

12.3

 

 3–4

0

0

0

0

 

Dry mouth

< 0.001

 0

9

90.0

52

23.6

 

 1–2

1

10.0

119

54.1

 

 3–4

0

0

49

22.3

 

Cranial neuropathy

0.473

 0

10

100

207

94.1

 

 1–2

0

0

13

5.9

 

 3–4

0

0

0

0

 

Peripheral neuropathy

1.000

 0

10

100

218

99.1

 

 1–2

0

0

2

0.9

 

 3–4

0

0

0

0

 

Endocrine dysfunction

1.000

 0

10

100

211

95.9

 

 1–2

0

0

9

4.1

 

 3–4

0

0

0

0

 

Temporal lobe necrosis

1.000

 0

10

100

205

93.2

 

 1–2

0

0

15

6.8

 

 3–4

0

0

0

0

 
  1. ENPG endoscopic nasopharyngectomy, IMRT intensity-modulated radiotherapy
  2. * Fisher’s exact test